Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Rheumatology
•
General Rheumatology
•
Infectious Disease
•
Vaccines
How are you counseling immunosuppressed patients regarding monkeypox vaccination?
Related Questions
What is your approach to RSV vaccination in immunocompromised patients?
How do you approach management of patients with active RA and recurrent non-severe C.diff?
For how long do you recommend treatment for latent tuberculosis prior to initiation of anti-TNF therapy?
How do you approach immunosuppression in patients with a positive Interferon Gamma Release Assay and prior intravesicular BCG treatment for bladder cancer?
How do you approach evaluation for indolent infection in patients with chronic erosive arthropathy?
When is it safe to resume DMARDs in a patient who was diagnosed with active TB and started on treatment?
Do you typically adjust or hold immunosuppression in a well-controlled RA patient who is being treated for Mycobacterium avium-intracellulare (MAI)?
How do you approach ongoing screening for TB in patients with a history of treated latent TB, but who have ongoing use of DMARDs and/or biologics given Quantiferon testing and PPD can remain positive?
What isolation policies are Rheumatology offices employing for both staff and patients diagnosed with COVID-19 given the new CDC guidelines?
How do you approach endocarditis prophylaxis for patients with rheumatic diseases undergoing invasive dental surgery and no history of joint replacement?
